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Abstract
Giant retinal tears (GRTs) are full‑thickness circumferential tears of more than 90 degrees of the retina that are
associated with vitreous detachment. They are related to ocular trauma, high myopia, aphakia, pseudophakia,
genetic mutations involving collagen and young age. GRTs comprise 1.5% of all rhegmatogenous retinal
detachments and the average age of incidence is 42 years. GRTs are more common in males, as 72% of all
cases occur in males. The incidence of GRTs in the general population is estimated to be 0.05 per 100,000
individuals. Common techniques used in the management of GRTs include fluid‑air exchange, pneumatic
retinopexy, scleral buckling, primary vitrectomy with gas or silicone oil tamponade, and combined scleral
buckle‑vitrectomies. However, management of GRTs poses a great challenge to physicians due to the high
risk of intra‑ and post‑operative complications and the many technical difficulties involved. The advent
of perfluorocarbon liquids (PFCL) and the use of micro‑incisional surgery for the treatment of GRTs has
provided new opportunities for the management of GTRs. Today, retinal reattachment can be achieved in
94‑100% of cases.
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INTRODUCTION
Giant retinal tears (GRTs) are defined as full‑thickness
circumferential tears of more than 90 degrees of
the retina associated with vitreous detachment. [1‑3]
Their management poses significant challenges due
to the many complications and technical difficulties
involved. Although GRTs can occur spontaneously,
they are often associated with a number of conditions;
these include ocular trauma, high myopia, aphakia,
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pseudophakia, genetic mutations involving collagen
and young age. [4‑7] Common techniques used to
treat GRTs include fluid‑air exchange, pneumatic
retinopexy, scleral buckling, primary vitrectomy with
gas or silicone oil tamponade, and combined scleral
buckle‑vitrectomies.[8] Perfluorocarbon liquids (PFCLs)
revolutionized the management of GRTs and the advent
of small gauge vitrectomy techniques have further
optimized the treatment outcomes.
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GRTs comprise about 1.5% of rhegmatogenous
retinal detachments.[9] The average age of incidence is
42 years.[2,9] There is usually a higher incidence in males
than females, with males comprising 72% of cases.[2] This
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condition can occur as a result of a number of baseline
conditions. About 54% of GRTs are idiopathic, 12.3%
result from trauma, 25% result from high myopia,
and 14% result from other hereditary conditions such
as Marfan’s, Stickler‑Wagner, and Ehrler Danlos
syndromes.[2,3,10,11] About 12.8% of patients develop
bilateral GRTs.[9,12] The reported estimates of incidence
put this condition at 0.05 per 100,000 of the general
population per year.[2,12‑15] Despite its relative rarity, this
condition poses great challenges in management due to
its high risk of intra‑ and post‑operative complications
and the many technical difficulties involved.

Pathogenesis
Giant retinal tears occur from liquefaction of the
central vitreous associated with peripheral vitreous
condensation with concomitant traction in the region
of the vitreous base. The neurosensory retina tears
circumferentially in the area of the posterior vitreous
base.[9,12,16] The vitreous gel remains attached to the
anterior flap of retina, and the torn posterior retina
moves freely and can fold upon itself [Figure 1].[9] This
is the distinguishing feature between GRTs and retinal
dialyses. In retinal dialyses the vitreous is adherent to the
posterior aspect of the retinal tear, therefore the retina is
not very mobile.[17] As such the management of dialyses
is simpler than the repair of GRTs, as dialyses can often
be repaired just with laser or a scleral buckle.

Management
Medicine has come a long way in managing GRTs,
aided by the innovative use of perfluorcarbon
liquids described by Stanely Chang in 1987.[18] This
innovation increased the primary attachment rate
from 58% to over 94% and also helped bid farewell
to cumbersome and difficult surgical techniques
involving inverted surgical beds (Stryker frame)
and retinal tacks.[19,20] Today, management of GRTs
includes the use of laser photocoagulation, scleral
buckle, primary vitrectomy with perfluorocarbon
liquids (PFCL), and vitrectomy with scleral buckle or
combined phaco/vitrectomy.[3,9,21,22] Laser is effective
when the retina is attached. The edge of the tear is
treated with two to four rows of photocoagulation,
with particular emphasis to the radial edges of the
tear, treating anteriorly up to the ora serrata. Scleral
buckle is effective if the edge of the tear is not inverted,
and is a good option in children to preserve the lens
and limit positioning issues. Support of the edges of
the tear is important, as is thorough cryotherapy or
photocoagulation of the tear edges. Primary vitrectomy
with intraoperative use of perfluorocarbon liquids and
gas or silicone oil tamponade is necessary to unroll
and reposition a folded retina. Finally, if proliferate
vitreoretinopathy (PVR) is present, vitrectomy with a
94

scleral buckle can be used, and if a significant cataract
is present, combined phaco/vitrectomy is warranted.
The advent of micro‑incisional surgery has provided
new opportunities and challenges in the management of
the giant retinal tear detachment. Advantages of small
gauge vitrectomy include less trauma, smaller incisions,
reduced sclerotomy complications, and shortened
surgical times.[23] Challenges of 25‑gauge vitrectomy in
the management of giant tears include a slower removal
of vitreous, some difficulty reaching the anterior retina
and vitreous near the ora serrata, flexible instruments,
and a more prolonged aspiration time during the air/
fluid exchange.[24] This last step is crucial to prevent
retinal slippage and extra time should be allotted for
this maneuver when using smaller gauge instruments.

Surgical Techniques
Pseudophakic eyes

The specific micro‑incisional surgical techniques with
25 or 23g instrumentation for the management of
pseudophakic giant retinal tears without PVR include:
1‑ Removal of all the vitreous posteriorly and injection
of perfluoro‑octane liquid over the optic nerve. This is
done slowly with a dual‑bore cannula to prevent trauma
to the retina and avoid IOP elevations [Figure 2]. The
PFCL is injected as a single bubble to prevent fish eggs
and dispersion and to unfold and flatten the posterior
retina. 2‑ Once the retina is stabilized posteriorly,
the anterior vitreous and the anterior retinal flap are
removed [Figure 3]. Chandelier illumination and scleral
depression aid in the visualization of the anterior vitreous
and retina [Figure 4]. It is paramount to remove all
the vitreous, particularly in the area of the corners of
the tear since traction in that area is a common cause
of re‑detachment. 3‑ More PFCL is added to further
flatten the retina over the level of the edge of the tear. It
is important to keep the PFCL level below the infusion
to avoid the formation of fish eggs. If retinal folds are

Figure 1. Giant Retinal tear of 180°.
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present, the retina can be unfolded with forceps, with a
soft‑tip cannula or with a vitreous rake loop [Figure 5].
4‑ All of the anterior retinal flap and vitreous need to
be thoroughly removed with the vitrectomy probe,
with complete removal of all possible vitreous traction
on the corners since this is the area where any residual
vitreous traction can cause proliferation, traction and
re‑detachment. 5‑ If epiretinal membranes, star folds, or
macular holes are present, membranes and the ILM can
be peeled through the PFCL [Figure 6]. Staining with
ICG, Trypan Blue, or Brilliant Blue can be done prior
to PFCL injection in these situations if deemed useful.
6‑ Laser is applied to the corners and edge of the tear
in two to three rows up to the ora serrata, ideally using
a curved laser probe [Figure 7]. The rest of the retina is
checked as small breaks in the areas of attached retina can
be present and should be treated. 7‑ A fluid air exchange
is performed with aspiration of all the fluid anterior to
the PFCL bubble meniscus with a soft tip cannula. As
mentioned previously, it is imperative to remove all the

fluid anterior to the PFCL edge to prevent slippage of the
retina prior to removing the PFCL. The residual PFCL is
aspirated over the optic nerve and the eye is filled with a
minimally expanding concentration of perfluoropropane
or perfluoroethane gas. If using a silicone oil tamponade,
it is ideal to perform a direct silicone oil/PFCL exchange
with simultaneous injection of silicone oil and aspiration
of PFCL since this maneuver prevents slippage [Figure 8].

Figure 2. Injection of PFCL with a dual‑bore cannula to unfold
retina.

Figure 3. Removal of the anterior vitreous in the corners of
the tear.

Figure 4. Scleral depression with chandelier illumination in a
phakic eye to trim the anterior retinal flap.

Figure 5. Laser applied to the edges of the GRT.

Phakic eyes

If the eye is phakic, several management options are
possible. Preserving the lens can be done by utilizing
chandelier illumination so that scleral depression
can be performed to remove the anterior retinal flap
without causing trauma to the lens. Advantages of
preserving the lens are that if a cataract develops in
the future, accurate lens calculations can be performed,
and that the risk of losing pupillary dilation from the
lens removal is avoided. The main disadvantage of
preserving the lens is that it is more technically difficult
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Figure 6. Removal of ERMs with forceps through the PFCL
bubble.

plana lensectomy at the time of vitrectomy with either
concomitant or second procedure IOL implantation.
Advantages of these approaches include easier access to
the anterior structures of the eye. Disadvantages include
extra procedures, imprecise intraocular lens calculations,
and poor visibility due to pupillary miosis.
Proliferative vitreoretinopathy (PVR) is not uncommon
in eyes with giant tear detachments due to the significant
RPE dispersion and associated vitreous hemorrhage.
PVR occurs in 40‑50% of GRT detachments and is more
common in traumatic and long‑standing detachments.[25]
The repair technique includes pre‑placing an
encircling #41 or #42 silicone scleral buckle prior to the
vitrectomy to compensate for the shortening of the retinal
surface induced by membranes in PVR and to support
the vitreous base. Removal of all fibrous proliferation
on both surfaces of the retina is important to achieve
reattachment. Subretinal membranes are removed
prior to the injection of PFCL, and membranes on the
surface of the retina can be removed through the PFCL
bubble. [Figure 6] After the scleral buckle is placed,
vitrectomy is performed with the same techniques
described above. A scleral buckle is not routinely
recommended in eyes without PVR due to the creation
of retinal redundancy and ensuing guttering and retinal
slippage during the air‑fluid exchange.

Complications

Figure 7. Rows of laser photocoagulation around the 360° GRT.

The major complications associated with micro‑incisional
surgery for GRTs include retinal slippage during PFCL
removal; retinal folds associated with slippage, SB, or
high myopia; residual PFCL; cataract progression and
recurrent RD with PVR.[3,26]
Causes of re‑detachment include: anterior traction and
re‑proliferation at the corners of the tear, missed breaks
away from the tear, the presence of concomitant macular
holes, and the occurrence of PVR. Re‑detachment due
to PVR is more common in eyes with old detachments,
blood, pre‑existing membranes and pre‑existing PVR.[27]

RESULTS
The rate of reattachment following one procedure is
80‑90%, while the final reattachment rate is 94‑100%.[28,29]
However, if PVR is present, visual prognosis is poor
despite reattachment and anatomical success.[2]

Management of the other eye
Figure 8. Direct silicone oil/PFCL exchange with remaining
PFCL bubbles on the surface of the retina.

to clear the anterior vitreous and retinal flap without
causing a traumatic cataract. Other options in phakic
eyes include performing a phacoemulsification or pars
96

While GRTs are fairly rare, about 12.8% of patients
develop bilateral GRTs.[9,12] Therefore, it is important
to watch and manage the other eye to prevent bilateral
GRTs. Characteristics that suggest a high risk for
GRT include myopia over six diopters, white without
pressure, and vitreous condensation.[3,12] It is suggested
that peripheral pathology should be treated with

Journal of Ophthalmic and Vision Research Volume. 12, Issue. 1, January-March 2017

[Downloaded free from http://www.jovr.org on Monday, March 13, 2017, IP: 147.140.233.17]

Giant Retinal Tears; Berrocal et al

laser.[30,31] The use of a prophylactic buckle remains
controversial.[32,33]
In conclusion, the advent of modern vitrectomy
techniques, with micro‑incisional surgery, PFCLs,
chandelier illuminations and valved cannulas have
dramatically improved our anatomical success in the
management of GRT detachments. Surgical times are
reduced, complications have been minimized and
reattachment rates have been improved. Nevertheless,
attention needs to be given to the crucial steps of the
vitrectomy procedure to ensure anatomical success. The
most important pearls in the management of giant tear
retinal detachments include trimming the edges of the
tear well, identifying all distant breaks, injecting PFCL as
a single bubble and removing all anterior fluid by drying
the edges of the break thoroughly to prevent slippage.
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